Jackson Square Capital, LLC Kala Pharmaceuticals, Inc. Transaction History

Jackson Square Capital, LLC

  • $387 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Mar 05, 2021
SELL
$6.28 - $8.79 $1,632 - $2,285
-260 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$3.83 - $8.79 $497 - $1,142
-130 Reduced 33.33%
260 $2,000
Q4 2019

May 15, 2020
BUY
$3.36 - $4.81 $1,310 - $1,875
390 New
390 $1,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $7.69M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Jackson Square Capital, LLC Portfolio

Follow Jackson Square Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Square Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Square Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email